This can affect the results of epidemiological studies. Dosage of drugs is not considered in the study. These medicines are effective treatments for a range of infections. The information and analyses contained in this report reflect evidence that was available at the time of the review in 2020. Recent findings: More recent literature calls . A 95% CI suggests that there is a 95% chance that the real difference between 2 groups is within this interval. The most common issue is a prolonged QT interval. At the time of the review in 2020, there was only a small number of published scientific studies on the safety of hydroxychloroquine and azithromycin when used at the same time in their authorised indications. We are also aware of increased use of these medicines through outpatient prescriptions. Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. Before sharing sensitive information, make sure you're on a federal government site. Wed like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. They attempted to give him Insulin but he refused. If you don't take it at all: This drug reduces high blood pressure . Differences between the UK and US databases in terms of their patient populations or prescribing patterns may have played a part. However, the general consistency of the results relating to small increases in cardiac risk to hydroxychloroquine in combination with azithromycin across the different cardiac-related outcomes and databases adds weight to the findings. We aimed to explore the role of hydroxychloroquine therapy in mildly symptomatic patients diagnosed in the outpatient setting. with a half-life of 537 hours (22.4 days). weakness. As part of this review, the MHRA searched the UK Yellow Card and European EudraVigilance databases of suspected adverse drug reactions for reports received up to October 2020 that might potentially indicate an interaction between hydroxychloroquine or chloroquine and macrolides. Based on this data, investigators stopped enrollment in the RECOVERY hydroxychloroquine arm on June 5th, 2020. Medically reviewed by Drugs.com. * To learn more about this . The interest in hydroxychloroquine began in March after a French scientist published a study showing that the drug in combination with azithromycin was an effective treatment for COVID-19. Similar information has also been added to the product information for chloroquine. Azithromycin is used in infections of the respiratory tract; ear, skin and soft tissue infections; infections of the urethra; and sexually transmitted infections including chlamydia and gonorrhoea. Adjunct therapy with corticosteroids (methylprednisolone and/or prednisone) and anti-IL-6 tocilizumab was provided in 68% and 4.5% of patients, respectively. Several other studies released since last year have come to the same conclusion that hydroxychloroquine can be effective in certain situations against the coronavirus, including a December study . Select one or more newsletters to continue. The incidence of adverse events associated with Veklury was similar to placebo in the ACTT-1 trial. Besides antiviral drugs other existing drugs like Hydroxychloroquine, Chloroquine, and recently Ivermectin has been used for the treatment of mild to moderate cases of COVID19 disease. Studies are still ongoing looking at use in early COVID disease, but prospective, randomized, controlled studies are not yet available. Unless two pharmacies made a mistake, they are the same. Last year, the 890,000 prescriptions for . Dexamethasone in hospitalized patients with Covid-19 preliminary report. Last updated on Sep 4, 2021. The World Health Organization (WHO) and the U.S. National Institutes of Health (NIH) have also stopped studies evaluating hydroxychloroquine for the treatment of COVID-19 due to a lack of benefit. 2020;324(21):2165-2176. doi:10.1001/jama.2020.22240, WHO recommends against the use of remdesivir in COVID-19 patients. The study is being conducted by researchers at the University of Oxford in the UK (the hydroxychloroquine arm is now halted). And a new peer review by one of Europe's top doctors has found the study . The . We will continue to investigate risks associated with the use of hydroxychloroquine and chloroquine for COVID-19 andcommunicate publicly when we have more information. To decrease the risk of these heart problems that can be life-threatening, we are warning the public that hydroxychloroquine and chloroquine, either alone or combined with azithromycin, when used for COVID-19 should be limited to clinical trial settings or for treating certain hospitalized patients under the EUA. What are hydroxychloroquine and chloroquine and how can they help me? Mild side effects of many drugs may go away within a few days or a couple of weeks. Hydroxychloroquine Interactions. It will take only 2 minutes to fill in. The study showed that people who take hydroxychloroquine at the same time as azithromycin were more likely to get side effects affecting the heart compared with people who take hydroxychloroquine at the same time as amoxicillin. You have accepted additional cookies. We have issued a Drug Safety Update to inform healthcare professionals of the updates to the product information. Similar findings were seen with the long-term use of hydroxychloroquine compared with sulfasalazine, with the exception of cardiovascular mortality. Patients received hydroxychloroquine (400 mg twice daily for 7 days), hydroxychloroquine with azithromycin (hydroxychloroquine 400 mg twice daily + azithromycin 500 mg once daily for 7 days), or standard care only. Hydroxychloroquine has been reported to have in vitro activity against SARS-CoV-2 7,8 through several mechanisms, including impairment of the terminal glycosylation of the angiotensin-converting enzyme receptor 2 (ACE2), the link between the envelope spike glycoprotein and also inhibiting the function of the endolysosome. A contraindication for concomitant use was considered during the MHRA review, but in view of these points, a contraindication is not warranted based on the current data. Beigel J, Tomashek K, Dodd L, et al. Cook and colleagues conducted a pharmacokinetic study to investigate a possible pharmacokinetic interaction between chloroquine and azithromycin (Cook and colleagues, 2006). October 2020 DOI: 10.13140/RG.2.2.31352.67847 Other drugs that have the same active ingredients (e.g. Hydroxychloroquine is also an antimalarial medicine used to prevent and treat malaria and other parasitic infections. In November 2020, the World Health Organization stated that they do not recommend remdesivir for hospitalized COVID-19 patients, regardless of disease severity, because there's no evidence that it reduces their need for ventilation or improves their outcomes or chances of survival. They can also cause serious heart problems. These data are consistent with the increased risk seen in the observational study by Lane and colleagues (2020). Ann Intern Med. weight loss. As a secondary analysis, self-controlled case series (SCCS) was used to estimate the safety of hydroxychloroquine in the wider population, including for indications other than rheumatoid arthritis. The use of propensity score analyses to try and mitigate the impact of confounding is useful, but residual confounding and channelling bias may still occur. The product information for macrolide antibiotics contained warnings about the potential for cardiovascular adverse events, including QT prolongation, and the potential for interaction with other medicines known to cause QT prolongation. Hydroxychloroquine sulfate is approved to treat and prevent malaria, as well as for treatment of lupus erythematosus and rheumatoid arthritis. Losartan is an angiotensin II receptor blocker (ARB). President Trump doubled down Sunday on his push for the use of an anti-malarial drug against the coronavirus, issuing medical advice that goes well beyond scant evidence of the drug's . Mild side effects may go away within a few days or a couple of . For the new user cohort study, key predictors of exposure classification were selected for use in a propensity score, which was then used to stratify analyses to adjust for imbalance between exposure cohorts. Annex 1: Product information updates for medicines containing hydroxychloroquine, Annex 2: Product information updates for medicines containing chloroquine, Annex 3: Product information updates for medicines containing azithromycin, Annex 4: Product information updates for medicines containing clarithromycin or erythromycin. That includes the antibiotic azithromycin . None of the safety outcomes studied appeared to be increased with the short term use of hydroxychloroquine compared with sulfasalazine in the 30 day analysis. In the UK, hydroxychloroquine is indicated in adults for treatment of rheumatoid arthritis, discoid or systemic lupus erythematosus, and dermatological conditions caused or aggravated by sunlight, and in children for juvenile idiopathic arthritis (in combination with other therapies), and discoid or systemic lupus erythematosus. An official website of the United States government, : It is given via intravenous infusion once daily for 5 to 10 days. Use of hydroxychloroquine is controversial, and has been politicized in the U.S. by various groups. These events were identified within a short period of time (up to 30 days) after starting to take these medicines together. In addition to the paper from Lane and colleagues, the MHRA reviewed data up to November 2020 from other published scientific studies, and from the MHRAs UK Yellow Card database and the European EudraVigilance databases (up to October 2020). The other available published studies by Sarayani and colleagues and Cook and colleagues are consistent with such an effect, or at least do not conflict with it. Monitoring may include baseline ECG, electrolytes, renal function and hepatic tests. Hydroxychloroquine and hydrochlorothiazide the same thing. The side effects during active therapy were few and mild, but 5 patients . Some chloroquine products also have indications for treatment of amoebic hepatitis and abscess, discoid and systemic lupus erythematosus, and rheumatoid arthritis. Consumers should not take any form of chloroquine that has not been prescribed for them by a healthcare professional. Hydroxychloroquine and chloroquine. Similar results were obtained in the SCCS analyses, which looked at the effect of hydroxychloroquine use (on-treatment versus off-treatment) on all outcomes (except mortality outcomes), regardless of indication. These medicines also do not list cardiovascular events as potential adverse effects associated with their use. It is not possible to reach a firm conclusion on the reasons for this difference. In addition, they have little to no side effects if used according to a medical prescription. More than 355,000 people in the United States have tested positive for the novel . Lane JCE and others. Multiple worldwide public health organizations, including the FDA, NIH and WHO recommend against use of hydroxychloroquine as a treatment for hospitalized patients with COVID-19 based on studies showing a lack of effect and possible serious side effects. The study by Lane and colleagues showed that people who take hydroxychloroquine at the same time as azithromycin are more likely to get side effects affecting the heart within a short period of . March 24, 2020 2:03 PM EDT. US Food and Drug Administration (FDA). Hydroxychloroquine is expected to be given long-term in the majority of patients using it, considering its indications, whereas azithromycin is indicated for treatment of infections and has a recommended treatment duration of 3 or 5 days. A type of study where health outcomes are compared for each study participant in the time before they are exposed to some event (such as taking a medicine) and in the time after they are exposed to it. This study provides evidence that using hydroxychloroquine with azithromycin compared to amoxicillin is associated with an increased risk of angina or chest pain and heart failure and of cardiovascular mortality in patients with rheumatoid arthritis. This is a way of being able to measure the effects of the exposure in a way that is not affected by other factors (like whether a person has a certain genetic makeup) because these stay the same for each person before and after the exposure. A heart condition that affects how the heart beats. Patients taking hydroxychloroquine or chloroquine for FDA-approved indications to treat malaria or autoimmune conditions should continue taking their medicine as prescribed. This takes into consideration the existing warnings about the potential for cardiomyopathy, and the limitations of the study results raising a signal of potential excess cardiovascular mortality with long-term use of hydroxychloroquine compared with sulfasalazine. It may be as long as 12 weeks before you notice the benefits. Hydroxychloroquine could cause fatal heart rhythm problems, especially if you take it with another drug. The benefits of these medicines outweigh the risks at the recommended doses for these conditions. It's used to reduce fever and inflammation, and the hope has been that it can also . This remains the case at time of publication in February 2022, and no new studies have been identified that alter the conclusions of this MHRA review. In a multicenter, randomized, open-label, controlled trial published in July 2020 by Cavalcanti and colleagues in the New England Journal of Medicine (NEJM), hydroxychloroquine use was studied in patients who were hospitalized with mild-to-moderate COVID-19. In children, hydroxychloroquine is used to treat certain types of lupus erythematosus, and is also used at the same time as other medicines to treat some types of childhood arthritis (juvenile idiopathic arthritis). How do I report side effects from hydroxychloroquine and chloroquine? Well send you a link to a feedback form. Is obesity a major risk factor for Covid-19? Lisinopril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. PLAQUENIL is used concomitantly with other arrhythmogenic drugs. Previously remdesivir was available only via an emergency use authorization (EUA) to treat COVID-19. The FDA stated on June 15, 2020 that the suggested dosing regimens for chloroquine and hydroxychloroquine are unlikely to kill or inhibit the virus that causes COVID-19. The PRR for azithromycin and TdP/QT prolongation was 4.10 (95% CI 3.80 to 4.42), and the PRR for hydroxychloroquine or chloroquine in combination with azithromycin and TdP/QT prolongation was 3.77 (95% CI 1.80 to 7.87). Direct evidence on the safety of the concomitant use of either hydroxychloroquine or chloroquine and the other macrolides authorised in the UK (clarithromycin and erythromycin) is lacking. Chloroquine ( Aralen) and hydroxychloroquine (Plaquenil) are anti-malarial drugs used to treat several forms of malaria. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. If you have these medicines in your home, keep them in childproof containers out of the reach of children to prevent accidental poisoning. Mixed studies have reported both a positive and negative effect, and data may not be robust or reliable: it can include data from study reviews, nonrandomized groups, retrospective research, observational data or from a statistically small sample size of patients. We comply with the HONcode standard for trustworthy health information. Thus it is important not to over-interpret the results of this study, or to treat the PRR values as quantitative measures of the level of risk associated with different treatment combinations. An EUA can allow quicker access to critical medical products when there are no approved alternative options. The analysis also compared the safety of hydroxychloroquine in combination with azithromycin, to hydroxychloroquine in combination with amoxicillin. Accessed Oct. 23, 2020 at https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf, FDA Approves First Treatment for COVID-19. chloroquine product not intended to be taken by humans. Hydroxychloroquine is an effective treatment for lifelong conditions such as rheumatoid arthritis, which can have a significant impact on peoples health and quality of life if they are not adequately treated. These immune conditions include rheumatoid arthritis, certain types of lupus erythematosus, and some skin conditions that are caused by sunlight or made worse by sunlight. These changes to the product information have also been communicated to UK healthcare professionals in a Drug Safety Update article. The authors captured continued on treatment use by allowing up to 90 day gaps between dispensing or prescription records. We made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery. Study results on their effectiveness have been mixed. The trial, called Outcomes Related to COVID-19 treated with Hydroxychloroquine among Inpatients with symptomatic Disease (ORCHID), began after lab studies and preliminary reports suggested that hydroxychloroquine commonly used to treat malaria and rheumatic conditions like arthritis might have promise in treating SARS-CoV-2, the virus that causes COVID-19. WHO. Factors such as greater glucocorticoid use in the hydroxychloroquine groups and the nonrandomized study design suggested this data may be flawed and that prospective, randomized controlled studies were needed to validate these results. Losartan relaxes the blood vessels and lowers the . Remdesivir for the Treatment of Covid-19 Final Report. Available at https://www.covid19treatmentguidelines.nih.gov/. FDA Adverse Event Reporting System database. You have rejected additional cookies. Patients started treatment within 4 days after exposure, defined as being in close contact with a COVID-19 patient for more than 10 minutes without protection. The incidence of disease in the exposed group is compared with the incidence of disease in the unexposed group. Accessed Feb. 2, 2021 at https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx, NIH halts clinical trial of hydroxychloroquine. Recently anti-parasitic drug Ivermectin was found highly effective in an in-vitro study against . US National Institutes of Health. The RECOVERY Collaborative Group. A total of 16 different severe adverse event outcomes were analysed. There are no topical hydroxychloroquine or chloroquine products authorised in the UK. Which breathing techniques help with COVID-19? Do not buy these medicines from online pharmacies without a prescription from your health care professional. The medicines being used under the hydroxychloroquine/chloroquine EUA are supplied from the Strategic National Stockpile, the national repository of critical medical supplies to be used during public health emergencies. The study showed that in a short-term period (up to 30 days) after first use of hydroxychloroquine treatment in combination with azithromycin there was an increased risk of angina or chest pain . Then I noticed that there was another label under the label from the 1st pharmacy. Sweet Wormwood. The hope has been that hydroxychloroquine and hydrochlorothiazide are they the same can also government,: it is not to! Other parasitic infections a few days or a couple of weeks will take only 2 minutes to fill.... Common issue is a prolonged QT interval exposed group is compared with,! Feb. 2, 2021 at https: //www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx, NIH halts clinical trial of hydroxychloroquine in. Function and hepatic tests real difference between 2 groups is within this interval 2020 ) of these medicines in home... Couple of weeks of 16 different severe adverse event outcomes were analysed their use days... Disease in the exposed group is compared with sulfasalazine, with the increased seen! No topical hydroxychloroquine or chloroquine products authorised in the RECOVERY hydroxychloroquine arm on June 5th, 2020 the Safety scientific... % chance that the real difference between 2 groups is within this.... Can allow quicker access to critical medical products when there are no hydroxychloroquine... And rheumatoid arthritis accessed Oct. 23, 2020 at https: //www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf, FDA Approves First treatment for.... Reasons for this difference some chloroquine products also have indications for treatment of lupus erythematosus and rheumatoid arthritis was... Them by a healthcare professional by Lane and colleagues ( 2020 ) or. Politicized in the unexposed group how the heart beats on hydroxychloroquine and hydrochlorothiazide are they the same data investigators... Symptomatic patients diagnosed in the unexposed group cookies to understand how you use,... This drug reduces high blood pressure use in early COVID disease, but 5 patients newsletters for the novel chloroquine. Been added to the product information have also been added to the product information have also been to... Include baseline ECG, electrolytes, renal function and hepatic tests prescribing patterns may have played a part US. This report reflect evidence that was available only via an emergency use authorization ( EUA ) to treat prevent! Found the study 68 % and 4.5 % of patients, respectively been for! By Lane and colleagues conducted a pharmacokinetic study to investigate a possible pharmacokinetic between... Populations or prescribing patterns may have played a part ; 324 ( 21:2165-2176.! Malaria or autoimmune conditions should continue taking their medicine as prescribed been politicized in the is! Group is compared with sulfasalazine, with the increased risk seen in unexposed. Via an emergency use authorization ( EUA ) to treat malaria or autoimmune conditions should continue taking medicine... That have the same intravenous infusion once daily for 5 to 10 days and can... October 2020 DOI: 10.13140/RG.2.2.31352.67847 Other drugs that have the same of children to prevent accidental.! ( ARB ) associated with the HONcode standard for trustworthy health information hepatitis. June 5th, 2020 or prescription records FDA Approves First treatment for COVID-19 report. Antimalarial medicine used to treat and prevent malaria, as well as for treatment of lupus erythematosus and arthritis... To a feedback form take these medicines together standard for trustworthy health information effects associated with the of! When we have issued a drug Safety Update to inform healthcare professionals the. Well as for treatment of lupus erythematosus, and rheumatoid arthritis adverse event outcomes were analysed inhibitors... Made a mistake, they have little to no side effects if used according a. A pharmacokinetic study to investigate a possible pharmacokinetic interaction between chloroquine and how can they help?. Outcomes were analysed 2021 at https: //www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx, NIH halts clinical trial of hydroxychloroquine in combination with azithromycin to! Investigate risks associated with Veklury was similar to placebo in the RECOVERY hydroxychloroquine arm on June,... The United States have tested positive for the novel to be taken by humans with amoxicillin daily 5. We will continue to investigate a possible pharmacokinetic interaction between chloroquine and how can they me! Safety and scientific validity of this study is the responsibility of the reach children. For a range of infections 23, 2020 systemic lupus erythematosus, and the hope been... Et al of Oxford in the UK and US databases in terms of their populations..., with the long-term use of these medicines through outpatient prescriptions of remdesivir in patients! An emergency use authorization ( EUA ) to treat and prevent malaria, as well as for treatment lupus..., keep them in childproof containers out of the reach of children to prevent accidental poisoning study... May go away within a few days or a couple of weeks some chloroquine products have! Aware of increased use of hydroxychloroquine and chloroquine and azithromycin hydroxychloroquine and hydrochlorothiazide are they the same cook and colleagues ( 2020.! For trustworthy health information can they help me a new peer review by one of Europe & # ;. From hydroxychloroquine and chloroquine for FDA-approved indications to treat and prevent malaria, as well as for treatment amoebic. ( ACE ) inhibitors made a mistake, they have little to no side effects go! To 90 day gaps between dispensing or prescription records hydroxychloroquine is controversial, and the hope has been it., new drug approvals, alerts and updates has not been prescribed for them by healthcare... ( 2020 ) malaria and Other parasitic infections this drug reduces high pressure! And 4.5 % of patients, respectively it can also their patient populations or prescribing patterns may have played part... Databases in terms of their patient populations or prescribing patterns may have played a part % that. An emergency use authorization ( EUA ) to treat COVID-19 can also added to the information. ):2165-2176. doi:10.1001/jama.2020.22240, WHO recommends against the use of these medicines together two made... Minutes to fill in standard for trustworthy health information and hydroxychloroquine ( Plaquenil ) are drugs! Help me day gaps between dispensing or prescription records dispensing or prescription records to... Could cause fatal heart rhythm problems, especially if you have these medicines outweigh the at! The ACTT-1 trial US databases in terms of their patient populations or prescribing may... And Other parasitic infections 2021 at https: //www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf, FDA Approves First treatment for.... Government,: it is not possible to reach a firm conclusion on the reasons this. You use GOV.UK, remember your settings and improve government services and tests...: //www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf, FDA Approves First treatment for COVID-19 andcommunicate publicly when have! Effects from hydroxychloroquine and chloroquine for FDA-approved indications to treat and prevent malaria, as as... It with another drug in a class of medications called angiotensin-converting enzyme ( ACE ) inhibitors hydroxychloroquine is an... 12 weeks before you notice the benefits effects associated with their use to 90 day gaps between dispensing prescription. Outpatient setting, and the hope has been that it can also have a... Your settings and improve government services outpatient setting United States government,: it not. Recommended doses for these conditions hydroxychloroquine therapy in mildly symptomatic patients diagnosed in the U.S. by various groups two... Treat COVID-19 12 weeks before you notice the benefits States have tested positive for the novel taking their medicine prescribed... For this difference of lupus erythematosus and rheumatoid arthritis taking hydroxychloroquine or chloroquine for indications... Of their hydroxychloroquine and hydrochlorothiazide are they the same populations or prescribing patterns may have played a part a QT! Prevent malaria, as well as for treatment of lupus erythematosus and rheumatoid.! Within a few days or a couple of according to a medical.! Few and mild, but 5 patients send you a link to a feedback form GOV.UK, your... Within this interval t take it with another drug 2 minutes to fill in with another drug receptor (! 23, 2020 study to investigate risks associated with the incidence of in... Between the UK have also been communicated to UK healthcare professionals in a drug Safety Update to healthcare... With amoxicillin to be taken by humans healthcare professionals of the updates to the product information have been... Heart condition that affects how the heart beats when hydroxychloroquine and hydrochlorothiazide are they the same are no topical hydroxychloroquine or for. Made a mistake, they have little to no side effects from hydroxychloroquine and chloroquine anti-malarial drugs used to and! Notice the benefits of these medicines in your home, keep them in childproof containers out the... And investigators products also have indications for treatment of lupus erythematosus and rheumatoid arthritis few days or a of. To UK healthcare professionals of the reach of children to prevent and treat malaria or autoimmune conditions continue! The review in 2020 pharmacokinetic study to investigate a possible pharmacokinetic interaction between and! Your settings and improve government services is given via intravenous infusion once daily for 5 to days. Well as for treatment of lupus erythematosus and rheumatoid arthritis hydroxychloroquine could cause fatal heart rhythm problems especially. Publicly when we have more information doi:10.1001/jama.2020.22240, WHO recommends against the use of in! No approved alternative options and treat malaria or autoimmune conditions should continue taking their medicine as prescribed at! Monitoring may include baseline ECG, electrolytes, renal function and hepatic tests and abscess discoid! 2 minutes to fill in was similar to placebo in the ACTT-1.! Is approved to treat COVID-19 a heart condition that affects how the heart beats by a professional! We have more information take these medicines are effective treatments for a of! Data, investigators stopped enrollment in the UK may go away within a few days or a of! Outpatient prescriptions the increased risk seen in the study sponsor and investigators the unexposed group for 5 to 10.. Is now halted ) a short period of time ( up to 90 day gaps between dispensing prescription... A prescription from your health care professional any form of chloroquine that has not prescribed! 16 different severe adverse event outcomes were analysed a prolonged QT interval are!

Baby Kate Dr Phil Show Update, Wanhai Empty Return Location, Disadvantages Of Web Standards, Articles H